quantisnow
FeedTopReportsPricing
⌘K
Live feed
11:26:08·8d
ANALYSTRating
ResMed Inc. logo

Analyst initiated coverage on ResMed

RMD· ResMed Inc.
Health Care
Original source

Companies

  • RMD
    ResMed Inc.
    Health Care

Recent analyst ratings

  • Apr 15UpdateAnalyst-
  • Dec 16UpdateRobert W. Baird$275.00
  • Sep 18UpdateCitigroup$330.00
  • Sep 2UpdateCLSA-
  • Jul 16UpdateRBC Capital Mkts$294.00
  • Jul 15UpdateRBC Capital Mkts$294.00

Related

  • INSIDER14d
    SEC Form 4 filed by Farrell Michael J.
  • INSIDER20d
    SEC Form 4 filed by Sandercock Brett
  • INSIDER21d
    SEC Form 4 filed by Farrell Peter C
  • SEC22d
    SEC Form 144 filed by ResMed Inc.
  • PR22d
    Resmed to Report Third Quarter Fiscal 2026 Earnings on April 30, 2026
  • SEC27d
    Amendment: SEC Form SCHEDULE 13G/A filed by ResMed Inc.
  • INSIDER43d
    Chairman and CEO Farrell Michael J. exercised 4,991 units of ResMed Common Stock at a strike of $146.34 and sold $1,252,902 worth of ResMed Common Stock (4,991 units at $251.03) (SEC Form 4)
  • INSIDER49d
    Director Farrell Peter C sold $520,440 worth of ResMed Common Stock (2,000 units at $260.22), decreasing direct ownership by 3% to 62,773 units (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022